1-4 of 4
runx1 translocation partner 1 protein
Close
Sort by
Journal Articles

Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801

Clinical Trials & Observations
Guido Marcucci, Susan Geyer, Kristina Laumann, Weiqiang Zhao, Donna Bucci, Geoffrey L. Uy, William Blum, Ann-Kathrin Eisfeld, Timothy S. Pardee, Eunice S. Wang, Wendy Stock, Jonathan E. Kolitz, Jessica Kohlschmidt, Krzysztof Mrózek, Clara D. Bloomfield, Richard M. Stone, Richard A. Larson
Journal: Blood Advances
Blood Adv (2020) 4 (4): 696–705.
https://doi.org/10.1182/bloodadvances.2019000492
Published: 2020
Journal Articles

An update on the molecular pathogenesis and potential therapeutic targeting of AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1

Sayer Al-Harbi, Mahmoud Aljurf, Mohamad Mohty, Fahad Almohareb, Syed Osman Ali Ahmed
Journal: Blood Advances
Blood Adv (2020) 4 (1): 229–238.
https://doi.org/10.1182/bloodadvances.2019000168
Published: 2020
Journal Articles

Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11

Clinical Trials & Observations
Yuichi Ishikawa, Naomi Kawashima, Yoshiko Atsuta, Isamu Sugiura, Masashi Sawa, Nobuaki Dobashi, Hisayuki Yokoyama, Noriko Doki, Akihiro Tomita, Toru Kiguchi, Shiro Koh, Heiwa Kanamori, Noriyoshi Iriyama, Akio Kohno, Yukiyoshi Moriuchi, Noboru Asada, Daiki Hirano, Kazuto Togitani, Toru Sakura, Maki Hagihara, Tatsuki Tomikawa, Yasuhisa Yokoyama, Norio Asou, Shigeki Ohtake, Itaru Matsumura, Yasushi Miyazaki, Tomoki Naoe, Hitoshi Kiyoi
Journal: Blood Advances
Blood Adv (2020) 4 (1): 66–75.
https://doi.org/10.1182/bloodadvances.2019000709
Published: 2020
Includes: Supplemental data
Journal Articles

Myeloid translocation gene CBFA2T3 directs a relapse gene program and determines patient-specific outcomes in AML

Nickolas Steinauer, Chun Guo, Chunfa Huang, Madeline Wong, Yifan Tu, Carl E. Freter, Jinsong Zhang
Journal: Blood Advances
Blood Adv (2019) 3 (9): 1379–1393.
https://doi.org/10.1182/bloodadvances.2018028514
Published: 2019
Includes: Supplemental data